IRIS
SMIRNE, Carlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.349
NA - Nord America 2.790
AS - Asia 2.253
SA - Sud America 310
AF - Africa 69
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.775
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.722
SG - Singapore 905
RU - Federazione Russa 855
IE - Irlanda 604
CN - Cina 453
IT - Italia 423
DE - Germania 378
SE - Svezia 314
VN - Vietnam 305
HK - Hong Kong 259
BR - Brasile 241
FR - Francia 227
UA - Ucraina 198
FI - Finlandia 125
IN - India 102
GB - Regno Unito 82
KR - Corea 54
ID - Indonesia 40
CA - Canada 36
AR - Argentina 32
PL - Polonia 30
BJ - Benin 25
BD - Bangladesh 24
AT - Austria 22
CZ - Repubblica Ceca 22
MX - Messico 22
ZA - Sudafrica 20
BE - Belgio 16
TR - Turchia 16
IQ - Iraq 14
JP - Giappone 14
NL - Olanda 14
EC - Ecuador 12
CL - Cile 10
ES - Italia 10
IR - Iran 9
PH - Filippine 8
JO - Giordania 6
KE - Kenya 6
PK - Pakistan 6
TH - Thailandia 6
UZ - Uzbekistan 6
AL - Albania 5
CO - Colombia 5
EG - Egitto 5
VE - Venezuela 5
CH - Svizzera 4
LT - Lituania 4
AU - Australia 3
DZ - Algeria 3
MA - Marocco 3
NP - Nepal 3
OM - Oman 3
PY - Paraguay 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
HR - Croazia 2
IL - Israele 2
JM - Giamaica 2
LV - Lettonia 2
MK - Macedonia 2
PS - Palestinian Territory 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GH - Ghana 1
GM - Gambi 1
GT - Guatemala 1
HN - Honduras 1
IM - Isola di Man 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LY - Libia 1
MY - Malesia 1
PA - Panama 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.775
Salva come PNG Salva come JPEG
Città #
Dublin 604
Jacksonville 360
San Jose 358
Hong Kong 254
Ashburn 207
Singapore 193
Dearborn 166
Chandler 152
Beijing 133
Ho Chi Minh City 91
Wilmington 90
Moscow 87
Los Angeles 84
Ann Arbor 81
Piemonte 76
Lauterbourg 72
Lawrence 71
Princeton 71
Hanoi 70
Milan 61
San Mateo 58
Seoul 53
Novara 46
Buffalo 45
Munich 42
Andover 41
New York 34
Turin 31
São Paulo 30
Jakarta 29
Santa Clara 28
Nuremberg 27
Frankfurt am Main 26
Warsaw 26
Cotonou 25
Council Bluffs 25
Helsinki 21
Houston 21
Brno 20
Brooklyn 19
Dallas 18
Guangzhou 18
Nanjing 18
Hillsboro 17
Orem 17
Atlanta 16
Brussels 16
Dong Ket 16
Boardman 15
Denver 15
Johannesburg 15
Chennai 14
Haiphong 14
Tianjin 14
Chicago 13
Hefei 13
London 13
Woodbridge 13
Poplar 12
Redondo Beach 12
Da Nang 11
Falkenstein 11
Norwalk 11
Rome 11
Stockholm 11
Tokyo 11
Düsseldorf 10
Mexico City 10
Mumbai 10
Shanghai 10
Manchester 9
Montreal 9
Philadelphia 9
Seattle 9
Toronto 9
Boston 8
Bremen 8
Turku 8
City of London 7
Grafing 7
Phoenix 7
Strasbourg 7
Vercelli 7
Alessandria 6
Amman 6
Augusta 6
Berlin 6
Fairfield 6
Jinan 6
Kunming 6
Nairobi 6
Amsterdam 5
Ankara 5
Baghdad 5
Biên Hòa 5
Brasília 5
Can Tho 5
Dhaka 5
Fortaleza 5
Guayaquil 5
Totale 4.530
Salva come PNG Salva come JPEG
Nome #
Expression of the interferon-inducible proteins MxA and IFI16 in liver allografts 275
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 248
Genetic polymorphisms of inflammatory cytokines and liver fibrosis progression due to recurrent hepatitis C 224
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 190
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 174
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment 156
Antiviral treatment of hepatitis C improves glucose metabolism along the entire spectrum from normal glucose tolerance to diabetes 139
Validation of the Hepatoma Arterial Embolization Prognostic Score in European and Asian Populations and Proposed Modification. 134
Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma 131
Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: A multi-center comparative study 129
Red cell distribution width and platelet count as biomarkers of pulmonary arterial hypertension in patients with connective tissue disorders 127
Detrimental Impact of Interferon-Based Regimens for Chronic Hepatitis C on Vitamin D/Parathyroid Hormone Homeostasis 126
Oxidative Stress in Non-Alcoholic Fatty Liver Disease 126
Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis 125
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents 123
Diagnostic value of FibroTest with normal serum aminotransferases 122
Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential 120
Plasma microvesicles in patients admitted to the emergency department for mild traumatic brain injury: First clues to understand their role 120
Differential expression of transforming growth factors-beta1, -beta2 and -beta3 in human colon carcinoma 115
The surgical treatment of lung metastases. The prognostic factors and the indications for the surgical approach 114
Cooperative induction of a tolerogenic dendritic cell phenotype by cytokines secreted by pancreatic carcinoma cells 114
Asymptomatic HBV and HCV carriers, bad breath and gengivitis 112
APOLIPOPROTEIN E GENOTYPES MODULATE FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C AND PERSISTENTLY NORMAL TRANSAMINASES 112
Unusual presentation of fatal disseminated varicella zoster virus infection in a patient with lupus nephritis: A case report 112
Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of the AST to platelet ratio index 111
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma 111
ACE genotype, body weight changes and target organ damage in renal transplant recipients 111
Antagonistic interactions between gemcitabine and 5-fluorouracil in the human pancreatic carcinoma cell line Capan-2 109
Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease 108
IL28B Polymorphism, Blood Interferon-alpha Concentration, and Disease Stage of HCV Mono-infected and HCV-HIV Co-infected Patients. 107
Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival 106
Interferon alpha concentrations in blood and peritoneal fluid during treatment for hepatitis C 105
Fibrosis Progression in HCV Carriers with Mild Hepatitis Who Possess the High-Repetition Variant of the DRD4 Gene, a Genetic Marker for Binge-Drinking and Risk-Seeking Behavior: A Longitudinal Study. 103
Extracellular Vesicles as a Potential Biomarker of Pulmonary Arterial Hypertension in Systemic Sclerosis 102
Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders 102
Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis 101
Acquired post partum hemophilia 100
Plasma Pattern of Extracellular Vesicles Isolated from Hepatitis C Virus Patients and Their Effects on Human Vascular Endothelial Cells 98
Low fibrosis progression of recurrent hepatitis C in apolipoprotein E epsilon4 carriers: relationship with the blood lipid profile 98
Durability of the response to peginterferon-α2b and ribavirin in patients with chronic hepatitis C 98
The spectrum of movement disorders in chronic liver disease: A cross-sectional study 98
The spectrum of movement disorders in chronic liver disease: a cross-sectional study 95
Sofosbuvir-based therapies in genotype 2 hepatitis C virus cirrhosis: A real-life experience with focus on ribavirin dose 93
Influence of angiotensin-converting enzyme I/D gene polymorphism on clinical and histological correlates of chronic hepatitis C 92
Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C. 91
Human pancreatic carcinoma cells secrete bioactive interleukin-18 after treatment with 5-fluorouracil: implications for anti-tumor immune response 90
Chlamydia trachomatis prevalence in North-West Italy 89
Vascular endothelial growth factor. From basic research to clinical application 89
Chronic Hepatitis C Infection Treated with Direct-Acting Antiviral Agents and Occurrence/Recurrence of Hepatocellular Carcinoma: Does It Still Matter? 87
Plasma Extracellular Vesicles from Preeclamptic Patients Trigger a Detrimental Crosstalk Between Glomerular Endothelial Cells and Podocytes Involving Endothelin-1 87
Hepatitis C in the elderly: a multicentre cross-sectional study by the Italian Association for the Study of the Liver. 86
Use, misuse and abuse of diuretics 86
High serum levels of Transforming Growth Factor-beta1, Interleukin-10 and Vascular Endothelial Growth Factor in pancreatic adenocarcinoma patients 85
Hepatic arterial infusion chemotherapy for Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma 84
T-cell mediated responses against alpha-foetoprotein in hepatocellular carcinoma: Relationship with hepatitis C virus infection, tumour phenotype and patients’ survival 84
Imatinib mesylate for the treatment of solid tumours: Recent trials and future directions 83
Clinical Characteristics and Outcomes in Patients with Chronic HBV Infection and Hospitalized for COVID-19 Pneumonia: A Retrospective Cohort Study 82
Liver biopsy and noninvasive alternatives in relationship to the duration of antiviral treatment for hepatitis C 82
Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation 82
Unsuspected strongyloidiasis in hospitalized elderly patients with and without eosinophilia 82
Clinical Features and Outcomes of Patients with Full Spectrum of COVID-19 Severity and Concomitant Herpesvirus Reactivation 81
Efficacy and Safety of Sofosbuvir and Ribavirin in an Italian Cohort of HCV Genotype 2 Elderly Cirrhotic Patients 80
Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma 80
Risk of hepatocellular carcinoma and death among cirrhotics who carry genetic variants of epidermal growth factor, Adiponutrin and 17β-Hydroxysteroid Dehydrogenase-13: a long-term cohort study 79
A novel likely pathogenetic variant p.(Cys235Arg) of the MEN1 gene in multiple endocrine neoplasia type 1 with multifocal glucagonomas. 79
Sex-related influence of angiotensin-converting enzyme polymorphisms on fibrosis progression due to recurrent hepatitis C after liver transplantation 79
The spectrum of movement disorders in chronic liver disease: a cross-sectional study 79
Exposure to Plasma From Non-alcoholic Fatty Liver Disease Patients Affects Hepatocyte Viability, Generates Mitochondrial Dysfunction, and Modulates Pathways Involved in Fat Accumulation and Inflammation 78
Impact of Age and Sex on Viral Load in Hepatitis C Virus Infection 77
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency. 77
Sexually transmitted diseases and pelvic inflammatory disease 76
Usefulness of six non-proprietary indirect markers of liver fibrosis in patients with chronic hepatitis C 71
Weight gain after liver transplantation and the I/D polymorphism of the angiotensin-converting enzyme gene 71
The c-kit/Stem Cell Factor in the cancerogenetic process of colon-rectal carcinoma. Biological and clinical aspects 70
Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation 70
The interleukin 28B rs12979860 C/T polymorphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases 70
The pro-apoptotic factors Fas Ligand and Trail. Molecular mechanisms, physiopathological role and therapeutic potential 69
Imatinib mesilate: New perspectives in the treatment of solid tumours 69
Hepatitis C Virus as a Possible Helper Virus in Human Hepatitis Delta Virus Infection 68
The Kings Score refines prognostic prediction in hepatocellular carcinoma: a novel application 68
Unveiling the Mystery of Adult-Onset Still’s Disease: A Compelling Case Report 66
KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes 66
Imatinib mesylate: new perspectives in the treatment of solid tumours 64
Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases 64
The Impact of the G6PD Gene Mutations in Patients with Chronic Hepatitis C Infection Treated with Direct-Acting Antivirals: A Multicenter Observational Study 62
Evaluation of plasma interferon alpha concentration as a marker of disease severity in human psoriasis 52
Nitric Oxide Signaling in Cardiovascular Physiology and Pathology: Mechanisms, Dysregulation, and Therapeutic Frontiers 42
Mitochondrial Dysfunction: The Cellular Bridge from Emo-tional Stress to Disease Onset. A narrative review 36
The Role of Vitamin D in Autoimmune Diseases 33
What is your next step? A case of how a misleading diagnosis can mask avoidable serious adverse effects of quetiapine 19
Thinking outside the box: a case of unexplained ascites in an adult 14
Totale 8.894
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.579
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.579
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021117 0 0 0 0 0 0 0 0 0 20 72 25
2021/2022570 12 22 93 58 35 15 64 19 48 28 67 109
2022/20231.273 141 55 67 33 65 130 27 73 618 6 44 14
2023/2024490 35 54 35 15 87 8 93 17 14 11 42 79
2024/20251.406 25 7 45 20 26 70 160 86 249 135 218 365
2025/20263.577 153 151 250 541 394 238 638 696 284 232 0 0
Totale 8.894